Neuronetics, Inc. (STIM)

Neuronetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	71.35	65.21	55.31	49.24	62.66
Revenue Growth (YoY)	9.42%	17.89%	12.32%	-21.41%	18.72%
Cost of Revenue	19.64	15.48	11.65	11.55	15.39
Gross Profit	51.71	49.72	43.66	37.69	47.27
Selling, General & Admin	72.74	75.5	63.3	50.8	60.45
Research & Development	9.52	9.34	7.92	9.2	13.75
Operating Expenses	82.26	84.83	71.22	60	74.2
Operating Income	-30.55	-35.11	-27.56	-22.31	-26.93
Interest Expense / Income	5.42	4.25	4.02	4.52	3.69
Other Expense / Income	-5.79	-2.2	-0.39	0.62	-1.57
Pretax Income	-30.19	-37.16	-31.19	-27.45	-29.04
Net Income	-30.19	-37.16	-31.19	-27.45	-29.04
Shares Outstanding (Basic)	29	27	25	19	18
Shares Outstanding (Diluted)	29	27	25	19	18
Shares Change	6.54%	5.58%	35.27%	2.48%	105.41%
EPS (Basic)	-1.05	-1.38	-1.22	-1.46	-1.58
EPS (Diluted)	-1.05	-1.38	-1.22	-1.46	-1.58
Free Cash Flow	-34.41	-34.01	-30.34	-29.12	-31.3
Free Cash Flow Per Share	-1.20	-1.26	-1.19	-1.55	-1.70
Gross Margin	72.47%	76.26%	78.93%	76.54%	75.44%
Operating Margin	-42.82%	-53.85%	-49.83%	-45.30%	-42.98%
Profit Margin	-42.31%	-56.99%	-56.39%	-55.75%	-46.35%
Free Cash Flow Margin	-48.22%	-52.15%	-54.85%	-59.13%	-49.95%
EBITDA	-22.76	-31.26	-26.11	-21.99	-24.29
EBITDA Margin	-31.90%	-47.94%	-47.21%	-44.66%	-38.77%
Depreciation & Amortization	2.01	1.65	1.06	0.94	1.07
EBIT	-24.77	-32.91	-27.17	-22.93	-25.36
EBIT Margin	-34.71%	-50.47%	-49.13%	-46.57%	-40.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).